Literature DB >> 31043574

Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.

Atsushi Aoyagi1,2, Carlo Condello3,4, Jan Stöhr1,4,5, Weizhou Yue1, Brianna M Rivera1, Joanne C Lee1, Amanda L Woerman1,4, Glenda Halliday6, Sjoerd van Duinen7, Martin Ingelsson8, Lars Lannfelt8, Caroline Graff9,10, Thomas D Bird11,12, C Dirk Keene13, William W Seeley4,14, William F DeGrado1,15, Stanley B Prusiner3,4,16.   

Abstract

The hallmarks of Alzheimer's disease (AD) are the accumulation of Aβ plaques and neurofibrillary tangles composed of hyperphosphorylated tau. We developed sensitive cellular assays using human embryonic kidney-293T cells to quantify intracellular self-propagating conformers of Aβ in brain samples from patients with AD or other neurodegenerative diseases. Postmortem brain tissue from patients with AD had measurable amounts of pathological Aβ conformers. Individuals over 80 years of age had the lowest amounts of prion-like Aβ and phosphorylated tau. Unexpectedly, the longevity-dependent decrease in self-propagating tau conformers occurred in spite of increasing amounts of total insoluble tau. When corrected for the abundance of insoluble tau, the ability of postmortem AD brain homogenates to induce misfolded tau in the cellular assays showed an exponential decrease with longevity, with a half-life of about one decade over the age range of 37 to 99 years. Thus, our findings demonstrate an inverse correlation between longevity in patients with AD and the abundance of pathological tau conformers. Our cellular assays can be applied to patient selection for clinical studies and the development of new drugs and diagnostics for AD.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31043574      PMCID: PMC6640844          DOI: 10.1126/scitranslmed.aat8462

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  85 in total

1.  Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.

Authors:  Jan Stöhr; Carlo Condello; Joel C Watts; Lillian Bloch; Abby Oehler; Mimi Nick; Stephen J DeArmond; Kurt Giles; William F DeGrado; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

2.  Structural Polymorphism of Alzheimer's β-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study.

Authors:  Matthew R Elkins; Tuo Wang; Mimi Nick; Hyunil Jo; Thomas Lemmin; Stanley B Prusiner; William F DeGrado; Jan Stöhr; Mei Hong
Journal:  J Am Chem Soc       Date:  2016-07-28       Impact factor: 15.419

3.  Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.

Authors:  Zhuohao He; Jing L Guo; Jennifer D McBride; Sneha Narasimhan; Hyesung Kim; Lakshmi Changolkar; Bin Zhang; Ronald J Gathagan; Cuiyong Yue; Christopher Dengler; Anna Stieber; Magdalena Nitla; Douglas A Coulter; Ted Abel; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Med       Date:  2017-12-04       Impact factor: 53.440

4.  Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study.

Authors:  J P Brion; A M Couck; E Passareiro; J Flament-Durand
Journal:  J Submicrosc Cytol       Date:  1985-01

5.  Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.

Authors:  Yvonne S Eisele; Ulrike Obermüller; Götz Heilbronner; Frank Baumann; Stephan A Kaeser; Hartwig Wolburg; Lary C Walker; Matthias Staufenbiel; Mathias Heikenwalder; Mathias Jucker
Journal:  Science       Date:  2010-10-21       Impact factor: 47.728

6.  Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples.

Authors:  Matilde Bongianni; Christina Orrù; Bradley R Groveman; Luca Sacchetto; Michele Fiorini; Giovanni Tonoli; Giorgio Triva; Stefano Capaldi; Silvia Testi; Sergio Ferrari; Annachiara Cagnin; Anna Ladogana; Anna Poleggi; Elisa Colaizzo; Dorina Tiple; Luana Vaianella; Santina Castriciano; Daniele Marchioni; Andrew G Hughson; Daniele Imperiale; Tatiana Cattaruzza; Gian Maria Fabrizi; Maurizio Pocchiari; Salvatore Monaco; Byron Caughey; Gianluigi Zanusso
Journal:  JAMA Neurol       Date:  2017-02-01       Impact factor: 18.302

7.  Fibril structure of amyloid-β(1-42) by cryo-electron microscopy.

Authors:  Lothar Gremer; Daniel Schölzel; Carla Schenk; Elke Reinartz; Jörg Labahn; Raimond B G Ravelli; Markus Tusche; Carmen Lopez-Iglesias; Wolfgang Hoyer; Henrike Heise; Dieter Willbold; Gunnar F Schröder
Journal:  Science       Date:  2017-09-07       Impact factor: 47.728

8.  Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines.

Authors:  Amanda L Woerman; Smita Patel; Sabeen A Kazmi; Abby Oehler; Yevgeniy Freyman; Lloyd Espiritu; Robert Cotter; Julian A Castaneda; Steven H Olson; Stanley B Prusiner
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

9.  Transmission and spreading of tauopathy in transgenic mouse brain.

Authors:  Florence Clavaguera; Tristan Bolmont; R Anthony Crowther; Dorothee Abramowski; Stephan Frank; Alphonse Probst; Graham Fraser; Anna K Stalder; Martin Beibel; Matthias Staufenbiel; Mathias Jucker; Michel Goedert; Markus Tolnay
Journal:  Nat Cell Biol       Date:  2009-06-07       Impact factor: 28.824

10.  Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau.

Authors:  Samuel J Jackson; Caroline Kerridge; Jane Cooper; Annalisa Cavallini; Benjamin Falcon; Claire V Cella; Alessia Landi; Philip G Szekeres; Tracey K Murray; Zeshan Ahmed; Michel Goedert; Michael Hutton; Michael J O'Neill; Suchira Bose
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

View more
  35 in total

1.  Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity.

Authors:  Jean-Marc M Grandjean; Alexander Y Jiu; John W West; Atsushi Aoyagi; Daniel G Droege; Manuel Elepano; Makoto Hirasawa; Masakazu Hirouchi; Ryo Murakami; Joanne Lee; Koji Sasaki; Shimpei Hirano; Takao Ohyama; Benjamin C Tang; Roy J Vaz; Masahiro Inoue; Steven H Olson; Stanley B Prusiner; Jay Conrad; Nick A Paras
Journal:  ACS Med Chem Lett       Date:  2020-01-30       Impact factor: 4.345

2.  Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure.

Authors:  Katerina Konstantoulea; Patricia Guerreiro; Meine Ramakers; Nikolaos Louros; Liam D Aubrey; Bert Houben; Emiel Michiels; Matthias De Vleeschouwer; Yulia Lampi; Luís F Ribeiro; Joris de Wit; Wei-Feng Xue; Joost Schymkowitz; Frederic Rousseau
Journal:  EMBO J       Date:  2021-11-29       Impact factor: 11.598

Review 3.  Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance.

Authors:  Melanie Alpaugh; Hélèna L Denis; Francesca Cicchetti
Journal:  Mol Psychiatry       Date:  2022-01       Impact factor: 15.992

Review 4.  Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases.

Authors:  Dan Li; Cong Liu
Journal:  Nat Rev Neurosci       Date:  2022-05-30       Impact factor: 38.755

5.  Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.

Authors:  Simon Dujardin; Caitlin Commins; Aurelien Lathuiliere; Pieter Beerepoot; Analiese R Fernandes; Tarun V Kamath; Mark B De Los Santos; Naomi Klickstein; Diana L Corjuc; Bianca T Corjuc; Patrick M Dooley; Arthur Viode; Derek H Oakley; Benjamin D Moore; Kristina Mullin; Dinorah Jean-Gilles; Ryan Clark; Kevin Atchison; Renee Moore; Lori B Chibnik; Rudolph E Tanzi; Matthew P Frosch; Alberto Serrano-Pozo; Fiona Elwood; Judith A Steen; Matthew E Kennedy; Bradley T Hyman
Journal:  Nat Med       Date:  2020-06-22       Impact factor: 53.440

6.  Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.

Authors:  Evan Lester; Felicia K Ooi; Nadine Bakkar; Jacob Ayers; Amanda L Woerman; Joshua Wheeler; Robert Bowser; George A Carlson; Stanley B Prusiner; Roy Parker
Journal:  Neuron       Date:  2021-04-12       Impact factor: 17.173

7.  Four distinct trajectories of tau deposition identified in Alzheimer's disease.

Authors:  Jacob W Vogel; Alexandra L Young; Neil P Oxtoby; Ruben Smith; Rik Ossenkoppele; Olof T Strandberg; Renaud La Joie; Leon M Aksman; Michel J Grothe; Yasser Iturria-Medina; Michael J Pontecorvo; Michael D Devous; Gil D Rabinovici; Daniel C Alexander; Chul Hyoung Lyoo; Alan C Evans; Oskar Hansson
Journal:  Nat Med       Date:  2021-04-29       Impact factor: 53.440

8.  Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET.

Authors:  Renaud La Joie; Adrienne V Visani; Orit H Lesman-Segev; Suzanne L Baker; Lauren Edwards; Leonardo Iaccarino; David N Soleimani-Meigooni; Taylor Mellinger; Mustafa Janabi; Zachary A Miller; David C Perry; Julie Pham; Amelia Strom; Maria Luisa Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Neurology       Date:  2020-12-01       Impact factor: 9.910

Review 9.  How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.

Authors:  George A Carlson; Stanley B Prusiner
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

Review 10.  The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.

Authors:  Peirong Gao; Lingqi Ye; Hongrong Cheng; Honglei Li
Journal:  Cell Mol Neurobiol       Date:  2020-07-27       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.